APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pseudomonas Aeruginosa Pneumonia Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pseudomonas Aeruginosa Pneumonia Drug Industry Growth and Trends Forecast to 2032

19 December 202579 pages

Choose your research edition.

Industry ResearchPseudomonas Aeruginosa Pneumonia Drug Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Pseudomonas Aeruginosa Pneumonia Drug Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Pseudomonas Aeruginosa Pneumonia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pseudomonas Aeruginosa Pneumonia Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pseudomonas Aeruginosa Pneumonia Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pseudomonas Aeruginosa Pneumonia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pseudomonas Aeruginosa Pneumonia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pseudomonas Aeruginosa Pneumonia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pseudomonas Aeruginosa Pneumonia Drug include Polyphor Ltd, MedImmune LLC, Emergent BioSolutions Inc and Aridis Pharmaceuticals LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pseudomonas Aeruginosa Pneumonia Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pseudomonas Aeruginosa Pneumonia Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pseudomonas Aeruginosa Pneumonia Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pseudomonas Aeruginosa Pneumonia Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pseudomonas Aeruginosa Pneumonia Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pseudomonas Aeruginosa Pneumonia Drug Market by Company

Polyphor Ltd

MedImmune LLC

Emergent BioSolutions Inc

Aridis Pharmaceuticals LLC

Pseudomonas Aeruginosa Pneumonia Drug Segment by Type

Aerucin

Panobacumab

MEDI-3902

EV-035

Others

Pseudomonas Aeruginosa Pneumonia Drug Segment by Application

Hospital

Clinic

Others

Pseudomonas Aeruginosa Pneumonia Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pseudomonas Aeruginosa Pneumonia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pseudomonas Aeruginosa Pneumonia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pseudomonas Aeruginosa Pneumonia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pseudomonas Aeruginosa Pneumonia Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pseudomonas Aeruginosa Pneumonia Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aerucin Table 2. Major Company of Panobacumab Table 3. Major Company of MEDI-3902 Table 4. Major Company of EV-035 Table 5. Major Company of Others Table 6. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Pseudomonas Aeruginosa Pneumonia Drug Industry Trends Table 28. Pseudomonas Aeruginosa Pneumonia Drug Industry Drivers Table 29. Pseudomonas Aeruginosa Pneumonia Drug Industry Opportunities and Challenges Table 30. Pseudomonas Aeruginosa Pneumonia Drug Industry Restraints Table 31. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Company (2021-2026) Table 33. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Company (2021-2026) Table 35. Global Pseudomonas Aeruginosa Pneumonia Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Pseudomonas Aeruginosa Pneumonia Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pseudomonas Aeruginosa Pneumonia Drug Major Company Production Sites and Headquarters Table 38. Global Pseudomonas Aeruginosa Pneumonia Drug Company, Product Type & Application Table 39. Global Pseudomonas Aeruginosa Pneumonia Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pseudomonas Aeruginosa Pneumonia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Polyphor Ltd Company Information Table 75. Polyphor Ltd Business Overview Table 76. Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio Table 78. Polyphor Ltd Recent Development Table 79. MedImmune LLC Company Information Table 80. MedImmune LLC Business Overview Table 81. MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio Table 83. MedImmune LLC Recent Development Table 84. Emergent BioSolutions Inc Company Information Table 85. Emergent BioSolutions Inc Business Overview Table 86. Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio Table 88. Emergent BioSolutions Inc Recent Development Table 89. Aridis Pharmaceuticals LLC Company Information Table 90. Aridis Pharmaceuticals LLC Business Overview Table 91. Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio Table 93. Aridis Pharmaceuticals LLC Recent Development Table 94. North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Units) Table 96. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2021-2026) Table 97. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Country (2027-2032) Table 99. North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country (2021-2026) Table 102. North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Pseudomonas Aeruginosa Pneumonia Drug Market Share Forecast by Country (2027-2032) Table 104. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Units) Table 106. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2021-2026) Table 107. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country (2021-2026) Table 112. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country (2021-2026) Table 122. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Share Forecast by Country (2027-2032) Table 124. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Units) Table 126. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2021-2026) Table 127. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country (2021-2026) Table 132. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country (2021-2026) Table 142. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Pseudomonas Aeruginosa Pneumonia Drug Distributors List Table 147. Pseudomonas Aeruginosa Pneumonia Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Pseudomonas Aeruginosa Pneumonia Drug Image Figure 2. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pseudomonas Aeruginosa Pneumonia Drug Sales (2021-2032) & (K Units) Figure 5. Aerucin Image Figure 6. Global Aerucin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Panobacumab Image Figure 8. Global Panobacumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. MEDI-3902 Image Figure 10. Global MEDI-3902 Sales YoY Growth (2021-2032) & (K Units) Figure 11. EV-035 Image Figure 12. Global EV-035 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type 2025 VS 2032 Figure 17. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pseudomonas Aeruginosa Pneumonia Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application 2025 VS 2032 Figure 37. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pseudomonas Aeruginosa Pneumonia Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pseudomonas Aeruginosa Pneumonia Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Aerucin
  • Panobacumab
  • MEDI-3902
  • EV-035
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Polyphor Ltd
  • MedImmune LLC
  • Emergent BioSolutions Inc
  • Aridis Pharmaceuticals LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pseudomonas Aeruginosa Pneumonia Drug Market by Type
  6. 1.3.1 Aerucin
  7. 1.3.2 Panobacumab
  8. 1.3.3 MEDI-3902
  9. 1.3.4 EV-035
  10. 1.3.5 Others
  11. 1.4 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Type
  12. 1.4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pseudomonas Aeruginosa Pneumonia Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pseudomonas Aeruginosa Pneumonia Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pseudomonas Aeruginosa Pneumonia Drug Industry Trends
  2. 2.2 Pseudomonas Aeruginosa Pneumonia Drug Industry Drivers
  3. 2.3 Pseudomonas Aeruginosa Pneumonia Drug Industry Opportunities and Challenges
  4. 2.4 Pseudomonas Aeruginosa Pneumonia Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pseudomonas Aeruginosa Pneumonia Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Pseudomonas Aeruginosa Pneumonia Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Pseudomonas Aeruginosa Pneumonia Drug Price (2021-2026)
  4. 3.4 Global Pseudomonas Aeruginosa Pneumonia Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pseudomonas Aeruginosa Pneumonia Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Pseudomonas Aeruginosa Pneumonia Drug Company, Product Type & Application
  7. 3.7 Global Pseudomonas Aeruginosa Pneumonia Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pseudomonas Aeruginosa Pneumonia Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pseudomonas Aeruginosa Pneumonia Drug Tier 1, Tier 2, and Tier 3
4 Pseudomonas Aeruginosa Pneumonia Drug Regional Status and Outlook
  1. 4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pseudomonas Aeruginosa Pneumonia Drug Historic Market Size by Region
  3. 4.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pseudomonas Aeruginosa Pneumonia Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pseudomonas Aeruginosa Pneumonia Drug Forecasted Market Size by Region
  7. 4.3.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pseudomonas Aeruginosa Pneumonia Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pseudomonas Aeruginosa Pneumonia Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pseudomonas Aeruginosa Pneumonia Drug by Application
  1. 5.1 Pseudomonas Aeruginosa Pneumonia Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Application
  6. 5.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pseudomonas Aeruginosa Pneumonia Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Polyphor Ltd
  2. 6.1.1 Polyphor Ltd Company Information
  3. 6.1.2 Polyphor Ltd Business Overview
  4. 6.1.3 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio
  6. 6.1.5 Polyphor Ltd Recent Developments
  7. 6.2 MedImmune LLC
  8. 6.2.1 MedImmune LLC Company Information
  9. 6.2.2 MedImmune LLC Business Overview
  10. 6.2.3 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio
  12. 6.2.5 MedImmune LLC Recent Developments
  13. 6.3 Emergent BioSolutions Inc
  14. 6.3.1 Emergent BioSolutions Inc Company Information
  15. 6.3.2 Emergent BioSolutions Inc Business Overview
  16. 6.3.3 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio
  18. 6.3.5 Emergent BioSolutions Inc Recent Developments
  19. 6.4 Aridis Pharmaceuticals LLC
  20. 6.4.1 Aridis Pharmaceuticals LLC Company Information
  21. 6.4.2 Aridis Pharmaceuticals LLC Business Overview
  22. 6.4.3 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Product Portfolio
  24. 6.4.5 Aridis Pharmaceuticals LLC Recent Developments
7 North America by Country
  1. 7.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
  2. 7.1.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
  6. 7.2.1 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
  2. 8.1.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
  6. 8.2.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
  2. 9.1.1 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
  2. 10.1.1 South America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
  6. 10.2.1 South America Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
  2. 11.1.1 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pseudomonas Aeruginosa Pneumonia Drug Value Chain Analysis
  2. 12.1.1 Pseudomonas Aeruginosa Pneumonia Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pseudomonas Aeruginosa Pneumonia Drug Production Mode & Process
  7. 12.2 Pseudomonas Aeruginosa Pneumonia Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pseudomonas Aeruginosa Pneumonia Drug Distributors
  10. 12.2.3 Pseudomonas Aeruginosa Pneumonia Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst